NASDAQ: FBIOP - Fortress Biotech, Inc.

Yield per half year: -57.16%
Dividend yield: +17.73%
Sector: Healthcare

Fortress Biotech, Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 48.77 -100% -1.37 -100%
P/S 1.17 33.77 -96.54%
P/BV 62.3 4.83 1190.4%
P/FCF 0 61 -100%
Ev/Ebitda -0.8122 -22.17 -96.34%
Ev/S 1.26 22.57 -94.42%
Ev/FCF -0.7815 68.76 -101.14%
E/P 0 0.0178 -100%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-155.2 4.97 -3221.5% -231.16 -32.86%
ROE -268.97 9.61 -2898.41%
ROA -36.2 0.3443 -10614.04%
ROIC 0 7.63 -100%
ROS -71.75 -25.17 185.06%
ROCE -8773.91 15.45 -56890.81%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.536 -3.68 -85.42% -0.5413 -0.9642%
Nеt Debt/Ebitda -0.0584 -3.44 -98.3%
Debt/Ratio 0.4197 0.1986 111.34%
Debt/Equity 0 1.66 -100%
Debt/Net Income -1.16 10.32 -111.23%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
10/10
17.73 0.541 3177.1% 16.9 +4.88%
Number of years of dividend growth 0 0.7368 -100%
DSI 0.8571 0.2256 280%
Average dividend growth -16.67 0.9598 -1836.31%
Average percentage for 5 years 16.9 0.4928 3330.08%
Average percentage for payments 0 43.56 -100%
Difference from average difference in sector 17.19

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
130.91 -57.64 -327.12%
Growth impulse Ebitda in 5 years 29 -90.94 -131.89%
Growth impulse Net Income in 5 years 182.03 -97.8 -286.12%
Growth impulse FCF in 5 years 30.58 -108.72 -128.13%
Growth impulse EPS in 5 years 1801.32 -142.05 -1368.09%
IP Score
5.66/10

Similar companies

Alexion

Amgen

ABIOMED

Gilead Sciences

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription